| Zidovudine - Wikipedia, the free encyclopedia Zidovudine (INN) or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the ... Read More |
| zidovudine (oral) medical facts from Drugs.com Physician reviewed zidovudine (oral) patient information - includes zidovudine description, dosage and directions. Read More |
| Zidovudine Official FDA information, side effects and uses. Accurate, FDA approved Zidovudine information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Retrovir (Zidovudine) Drug Information: Description, User Reviews ... Learn about the prescription medication Retrovir (Zidovudine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Zidovudine (AZT) Retrovir HIV Drug Side Effects, Dosing, Drug ... Zidovudine (AZT) (Retrovir) is a drug prescribed for the treatment of the human immunodeficiency virus infection (HIV). Side effects, dosing information, drug ... Read More |
| Zidovudine | HIV/AIDS Drug | Patient | AIDSinfo What is zidovudine? Zidovudine is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). It works by disrupting one of the early ... Read More |
| zidovudine: Definition from Answers.com Brand names: Retrovir®, Retrovir® IV. Chemical formula: Drug Forms: Zidovudine, ZDV oral syrup (below) Zidovudine, ZDV tablets; Zidovudine Oral capsule Read More |
| Zidovudine (Retrovir) - HIV InSite Gateway to HIV and AIDS Knowledge Approval: Zidovudine was the first drug to be approved for treatment of HIV infection. FDA approval was granted in 1987 for advanced HIV disease in adults and in 1990 ... Read More |
| zidovudine - definition of zidovudine in the Medical dictionary ... zidovudine /zi·do·vu·dine/ (zi-do´vu-dēn) a synthetic nucleoside analogue that inhibits replication of some retroviruses, including the human immunodeficiency ... Read More |
| Zidovudine Oral: MedlinePlus Drug Information [Posted 03/01/2011] ISSUE: FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. There has been ... Read More |
